Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14760128rdf:typepubmed:Citationlld:pubmed
pubmed-article:14760128lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:14760128lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:14760128lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:14760128lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:14760128lifeskim:mentionsumls-concept:C0045093lld:lifeskim
pubmed-article:14760128lifeskim:mentionsumls-concept:C0920321lld:lifeskim
pubmed-article:14760128lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:14760128lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:14760128lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:14760128lifeskim:mentionsumls-concept:C0526371lld:lifeskim
pubmed-article:14760128lifeskim:mentionsumls-concept:C1514555lld:lifeskim
pubmed-article:14760128lifeskim:mentionsumls-concept:C0915830lld:lifeskim
pubmed-article:14760128pubmed:issue2lld:pubmed
pubmed-article:14760128pubmed:dateCreated2004-2-4lld:pubmed
pubmed-article:14760128pubmed:abstractTextPKC412 (N-benzoyl-staurosporine), an oral inhibitor of protein kinase C, is capable of cell cycle inhibition and is endowed with anti-angiogenic properties. This dose-finding phase I study was designed to establish the maximum tolerated dose (MTD) of PKC412 when combined with cisplatin-gemcitabine.lld:pubmed
pubmed-article:14760128pubmed:languageenglld:pubmed
pubmed-article:14760128pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760128pubmed:citationSubsetIMlld:pubmed
pubmed-article:14760128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760128pubmed:statusMEDLINElld:pubmed
pubmed-article:14760128pubmed:monthFeblld:pubmed
pubmed-article:14760128pubmed:issn0923-7534lld:pubmed
pubmed-article:14760128pubmed:authorpubmed-author:HenrikssonRRlld:pubmed
pubmed-article:14760128pubmed:authorpubmed-author:Le...lld:pubmed
pubmed-article:14760128pubmed:authorpubmed-author:BerthaudPPlld:pubmed
pubmed-article:14760128pubmed:authorpubmed-author:RaymondEElld:pubmed
pubmed-article:14760128pubmed:authorpubmed-author:NovelloSSlld:pubmed
pubmed-article:14760128pubmed:authorpubmed-author:MonneratCClld:pubmed
pubmed-article:14760128pubmed:authorpubmed-author:FaivreSSlld:pubmed
pubmed-article:14760128pubmed:issnTypePrintlld:pubmed
pubmed-article:14760128pubmed:volume15lld:pubmed
pubmed-article:14760128pubmed:ownerNLMlld:pubmed
pubmed-article:14760128pubmed:authorsCompleteYlld:pubmed
pubmed-article:14760128pubmed:pagination316-23lld:pubmed
pubmed-article:14760128pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:meshHeadingpubmed-meshheading:14760128...lld:pubmed
pubmed-article:14760128pubmed:year2004lld:pubmed
pubmed-article:14760128pubmed:articleTitlePhase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer.lld:pubmed
pubmed-article:14760128pubmed:affiliationDepartment of Medicine, Institut Gustave-Roussy, Villejuif, France.lld:pubmed
pubmed-article:14760128pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14760128pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:14760128pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:14760128pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14760128lld:pubmed